Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
-
Field
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 9 hours ago
, noninferiority trials, multiple endpoints, adaptive designs, Bayesian design and analysis methods, estimands, meta-analyses, benefit-risk analyses, subgroup analyses, biosimilars, patient experience data
-
causes of death among individuals initiating ESKD therapy. Participate in systematic reviews and meta-analyses examining factors associated with CKD awareness and related public health outcomes. Develop
-
claims and electronic health data to examine healthcare utilization, quality of care, treatment patterns, and outcomes among individuals with diabetes. Participate in systematic reviews and meta-analyses
-
technology management, or smart grids. Experience in development of mathematical meta-models, control strategies, optimization methods and algorithms, data analysis and machine learning techniques, techno
-
background in at least one of the following areas: renewable energy sources, power systems integration, energy technology management, or smart grids. Experience in development of mathematical meta-models
-
/abstract and full-text screening using established software platforms, and extract relevant clinical data from selected studies. Assessing the risk of bias and methodological quality of included studies
-
data from clinical trials and/or observational studies, including proficiency with statistical software such as R, STATA and/or SAS. Proven skills in systematic reviews, meta-analyses and evidence
-
to examine trends in comorbidities, survival, and causes of death among individuals initiating ESKD therapy. Participate in systematic reviews and meta-analyses examining factors associated with CKD awareness
-
diabetes. Participate in systematic reviews and meta-analyses examining factors associated with diabetes prevention, management, self-care, awareness, and health outcomes. Strengthen skills in longitudinal
-
, qualitative evidence synthesis and some using more complex methods such as individual participant data or network meta-analyses. This is an exciting opportunity to be part of a new vision for evidence synthesis